Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction (NCT03533517)

🧪 Interventions in This Study

• AccuCinch® Ventricular Restoration (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (18 Sites)

• University of California, San Francisco — San Francisco, California
• Emory University Hospital Midtown — Atlanta, Georgia
• University of Louisville — Louisville, Kentucky
• Cardiovascular Institute of the South — Houma, Louisiana
• Minneapolis Heart Foundation Institute — Minneapolis, Minnesota
• Nebraska Heart Institute / Nebraska Heart Hospital — Lincoln, Nebraska
• Hackensack University Medical Center — Hackensack, New Jersey
• Mt. Sinai — New York, New York
• Columbia University Medical Center/NYPH — New York, New York
• Montefiore Medical Center — The Bronx, New York
• The Christ Hospital — Cincinnati, Ohio
• Pinnacle Health Cardiovascular Institute — Harrisburg, Pennsylvania
• Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania
• University of Pennsylvania — Philadelphia, Pennsylvania
• Baylor College of Medicine St. Luke's Medical Center — Houston, Texas
• Intermountain Medical Center — Salt Lake City, Utah
• University of Virginia School of Medicine — Charlottesville, Virginia
• Carilion Roanoke Memorial — Roanoke, Virginia

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Heart Failure

• REDUCE LAP-HFREF TRIAL — New York, New York
• Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
• DASH Diet in Heart Failure Outpatients — Sacramento, California
• Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
• LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
• A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama

Explore by condition: All Heart Failure clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.